Compare AdaptHealth Corp (AHCO) vs Honeywell International Inc (HON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs Honeywell International Inc — how do they compare? AdaptHealth Corp trades at $5.8 (market cap $753.09M), while Honeywell International Inc trades at $235.28 (market cap $72.93B). The key difference: Honeywell International Inc is far larger — about 96.8× AdaptHealth Corp's market cap, and Honeywell International Inc pays a 1.22% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | HON | |
|---|---|---|
Market Cap | $753.09M | $72.93B |
Sector | Health | Industrials |
52-Week High | $13.38 | $248.79 |
52-Week Low | $5.22 | $188.14 |
Enterprise Value | $2.77B | $97.73B |
Dividend Yield | — | 1.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.77, up 10.54% today but remains under significant pressure following recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal revenue growth but negative profitability margins. Recent news highlights multiple securities fraud investigations and a strategic shift through the sale of its diabetes unit to focus on sleep and respiratory care.
Despite 75% analyst buy ratings and an $11 consensus price target suggesting substantial upside, immediate risks are elevated. The company faces execution challenges with fixed-price contracts, ongoing legal scrutiny, and consecutive earnings misses. Investors must weigh the potential recovery against substantial operational and legal headwinds.
Honeywell (HON) trades at $235.01, down 3.26% amid bearish technical signals and recent growth guidance concerns. The stock shows strong fundamentals with a P/E of 8.85, net margin of 21.58%, and consistent earnings beats. Recent corporate actions include a 2:1 reverse stock split and dividend payments, while business divestitures aim to sharpen focus on automation. Cash flow remains positive at $1.92B for 2025, though 2026 projections indicate a net outflow.
Outlook is mixed: valuation appears attractive with analyst consensus target of $320.54, but near-term risks include bearish technicals, debt-to-asset ratio rising to 47.66%, and potential growth deceleration. Investors may find long-term value if automation segments drive recovery, though volatility from recent spinoff underperformance warrants caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →
